Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer

Lickliter, J., Francesconi, A., Smith, G., Burge, M., Coulthard, A., Rose, S., Griffin, M., Wilks, A., Wyld, D. and Vasey, P. (2008). Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer. In: Journal of Clinical Oncology: ASCO Annual Meeting Abstracts. 2008 ASCO Annual Meeting, Chicago, IL, U.S.A., (3504-3504). 30 May - 3 June, 2008.


Author Lickliter, J.
Francesconi, A.
Smith, G.
Burge, M.
Coulthard, A.
Rose, S.
Griffin, M.
Wilks, A.
Wyld, D.
Vasey, P.
Title of paper Phase I evaluation of CYT997, a novel cytotoxic and vascular-disrupting agent, in patients with advanced cancer
Conference name 2008 ASCO Annual Meeting
Conference location Chicago, IL, U.S.A.
Conference dates 30 May - 3 June, 2008
Proceedings title Journal of Clinical Oncology: ASCO Annual Meeting Abstracts   Check publisher's open access policy
Journal name Journal of Clinical Oncology   Check publisher's open access policy
Place of Publication Alexandria, VA. U.S.A.
Publisher American Society of Clinical Oncology
Publication Year 2008
Sub-type Published abstract
ISSN 0732-183X
1527-7755
Volume 26
Issue Suppl.
Start page 3504
End page 3504
Total pages 1
Language eng
Subjects 1112 Oncology and Carcinogenesis
Q-Index Code EX
Q-Index Status Provisional Code
Institutional Status Unknown

 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 0 times in Thomson Reuters Web of Science Article
Google Scholar Search Google Scholar
Created: Mon, 15 Mar 2010, 11:09:53 EST by Ms Lynette Adams on behalf of Faculty Of Health Sciences